The Herpes Simplex Virus 1 Us11 Protein Cooperates with Suboptimal Amounts of Human Immunodeficiency Virus Type 1 (HIV-1) Rev Protein to Rescue HIV-1 Production  by Duc Dodon, Madeleine et al.
1
M
t
t
r
s
a
t
t
3
Virology 270, 43–53 (2000)
doi:10.1006/viro.2000.0275, available online at http://www.idealibrary.com onThe Herpes Simplex Virus 1 Us11 Protein Cooperates with Suboptimal Amounts of Human
Immunodeficiency Virus Type 1 (HIV-1) Rev Protein to Rescue HIV-1 Production
Madeleine Duc Dodon,*,1 Ivan Mikae´lian,† Alain Sergeant,† and Louis Gazzolo*
*Immuno-Virologie Mole´culaire et Cellulaire, UMR 5537, Centre National de la Recherche Scientifique-Universite´ Claude Bernard Lyon 1, Faculte´
de Me´decine Lyon-RTH Laennec, 69372 Lyon Cedex 08, France; and †U412 INSERM, Ecole Normale Supe´rieure de Lyon, 69364 Lyon, France
Received July 12, 1999; returned to author for revision February 17, 2000; accepted February 24, 2000
The human immunodeficiency virus type 1 (HIV-1) RNA-binding Rev protein governs the expression of structural and
enzymatic viral proteins at a posttranscriptional level. Binding of Rev to the stem-loop IIB (SLIIB) sequence of the
Rev-response element (RRE) within unspliced and singly spliced viral mRNAs and to the nuclear export signal-binding
receptor, hCRM1 (or exportin 1), is required for the export of these transcripts to the cytoplasm. We have previously
shown that herpes simplex virus type 1 (HSV-1) RNA-binding Us11 protein is able to bind the RRE and substitute for Rev
in inducing the expression of HIV-1 envelope glycoproteins. We show here that Us11 cannot substitute for Rev in
rescuing a rev-deleted HIV-1 provirus. However, HIV-1 production is observed when Us11 is expressed with suboptimal
amounts of Rev. An in vivo RNA–protein binding assay indicates that Us11 is unable to directly interact with the SLIIB
RNA but can bind Rev assembled on that stem–loop structure. This association of US11 with Rev, which was confirmed
by in vivo coimmunoprecipitation and GST-pulldown assays, therefore underlies a biological Us11–Rev cooperation.
Furthermore this cooperation was shown to remain susceptible to the effect of leptomycin B, which blocks the binding
of hCRM1 to the nuclear export signal of Rev. These observations performed with intron-containing constructs provide
evidence that HSV-1 Us11 protein is not directly involved in the cytoplasmic accumulation of viral mRNAs but may be
rather acting as an auxiliary protein, thus allowing this retroviral protein to fulfill the nuclear export of these transcripts
and to rescue HIV-1 production. © 2000 Academic Press
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The viral regulatory proteins, Rev and Rex, encoded by
human immunodeficiency virus, type 1 (HIV-1) and hu-
man T cell leukemia/lymphotropic virus, type 1 (HTLV-1),
respectively, are translated from multiply spliced viral
mRNAs. They intervene during the late phase of the viral
replicative cycle to induce the cytoplasmic accumulation
of unspliced and singly spliced viral mRNAs. The post-
transcriptional activity of Rev and Rex is therefore critical
for the synthesis of structural and enzymatic viral pro-
teins, thus allowing the production of infectious viral
particles (Ballaun et al., 1991; Bogerd et al., 1991; Cullen,
992; Grassman et al., 1991; Parslow, 1993; Pollard and
alim, 1998).
Although Rex and Rev lack significant sequence iden-
ity, these proteins share strong similarities in their struc-
ural organization. They contain an N-terminal arginine-
ich RNA-binding domain that interacts with RNA-target
equences, the Rex response element (XRE) for HTLV-1,
nd the Rev response element (RRE) for HIV-1, providing
he specificity for transport of XRE- or RRE-containing
ranscripts (Ballaun et al., 1991; Bogerd et al., 1991;a
c
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43rassman et al., 1991; Malim and Cullen, 1991). In addi-
ion, both Rex and Rev contain short, leucine-rich se-
uence elements termed activation domains, which can
e reciprocally exchanged between these two proteins
ithout affecting their functional activity (Hope et al.,
991). These activation domains have been recently
emonstrated to act as nuclear export signals (NES) by
inding human CRM1, (hCRM1) or exportin 1, and this
nteraction can be disrupted by the antibiotic leptomycin
(Fornerod et al., 1997; Fridell et al., 1996; Hope et al.,
991; Wolff et al., 1997). A third domain responsible for
he multimerization of these regulatory viral proteins has
een found to be critical for Rev and Rex function (Malim
nd Cullen, 1991).
In the absence of Rev, unspliced and singly spliced
iral RNAs cannot be exported because of either their
ntrapment into spliceosome complexes or the presence
f cis-acting regulatory sequences (CRS) within the gag-
ol, env, and RRE sequences. Rev therefore functions in
ompetition with the splicing/nuclear sequestration path-
ay, stabilizing the viral mRNAs and accelerating their
ntry into the Rev-mediated nuclear export pathway. Pre-
ious studies have established that optimal amounts of
ev are required for a productive HIV-1 infection, sug-
esting that a functional threshold is necessary to
chieve the export of viral RRE-containing RNAs to the
ytosol. The expression of singly spliced HIV-1 RNAs that
0042-6822/00 $35.00
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44 DUC DODON ET AL.encode the viral envelope glycoproteins requires lower
levels of Rev than that of unspliced mRNAs that code for
Gag and Pol. Whether Rev reaches this critical threshold
or not appears to be crucial in the establishment of and
release from a latent state of infection and consequently
in the development of acquired immunodeficiency syn-
drome (AIDS) (Pollard and Malim, 1998; Pomerantz et al.,
1992).
Various pathogenic agents have been considered as
potentially important cofactors in the pathogenesis of
AIDS. Among them, the ubiquitous human herpesviruses
with a particularly high prevalence in certain high-risk
populations have been shown to cause increased mor-
bidity and mortality in patients with AIDS (Cavert, 1997;
Mole et al., 1997; Quinn et al., 1987). Further, these
viruses stimulate HIV-1 expression in cultured lympho-
cytes and monocytes. Thus herpes simplex virus type 1
(HSV-1), which is able to grow in a large number of cell
types, including human peripheral blood T lymphocytes,
has been shown to potentiate HIV replication (Albrecht et
al., 1989; Calistri et al., 1999; Golden et al., 1992; Heng et
al., 1994; Ostrove et al., 1987; Vlach and Pitha, 1993).
We have previously shown that the Us11 gene product
of HSV-1 can functionally substitute for HTLV-1 Rex, and
to a lesser extent for HIV-1 Rev, in inducing the expres-
sion of retroviral envelope glycoproteins, providing the
first evidence that the product of an heterologous virus
can intervene at the posttranscriptional level of the life
cycle of human retroviruses (Diaz et al., 1996). However,
this ability was mostly investigated in transient transfec-
tion assays using vectors expressing HTLV-1 and HIV-1
envelope glycoproteins through intronless transcripts.
Thus Us11 was found to be unable to rescue HIV-1
expression from a rev-deleted infectious provirus, under-
lining a restricted biological activity.
To further understand the biological role of Us11 in the
replication of HIV-1, we undertook an evaluation of the
intervention of this HSV-1 protein in experiments using
either a rev-deficient HIV-1 provirus or RRE-containing
reporter constructs giving rise to spliceable precursor
RNAs. Here we document that Us11 is able to upregulate
HIV-1 production or the expression of the reporter protein
only in the presence of suboptimal amounts of Rev,
establishing a Rev–Us11 cooperation. Furthermore the
observation that the export of viral unspliced or singly
spliced mRNAs remains hCRM1-dependent suggests
that Us11 cannot be considered as a hCRM1-like factor
and is not directly involved in the cytoplasmic accumu-
lation of these transcripts. Finally, the lack of interaction
of Us11 with the SLIIB RNA of the RRE together with the
association of Us11 with Rev indicate that this HSV-1
protein is acting as an auxiliary protein, allowing Rev to
function below the critical threshold required for viral
production.RESULTS
Evidence of a Rev-Us11 cooperation in rescuing
a rev-deleted HIV-1 provirus
Previous studies have indicated that a nonproductive,
latent HIV-1 infection is established in the absence or in
the presence of a low (subthreshold) amount of Rev.
Likewise, the replication of a rev-deleted HIV-1 infectious
provirus is dependent on a critical amount of Rev pro-
vided in trans (Pomerantz et al., 1992). As indicated in the
Introduction, Us11 was found to be unable to rescue a
rev-deleted HIV-1 infectious provirus (Diaz et al., 1996).
We therefore investigated whether Us11 could comple-
ment the posttranscriptional activity of a subthreshold
amount of Rev by inducing viral expression from a rev-
deleted HIV-1 provirus. To this aim, HeLa cells were
cotransfected with pHIVDRev, together with increasing
amounts of a Rev expression plasmid (from 1 to 100 ng),
in the absence or presence of an Us11 expression plas-
mid. Transfection efficiency was monitored by cotrans-
fection of the Rev nonresponsive vector pRSV-SEAP,
which encodes the secreted alkaline phosphatase
(SEAP) indicator gene. To determine the level of HIV-1
replication, we measured the amount of the p24 Gag
protein in the culture media, 48 h later. Figure 1A shows
that, in the absence of Us11, p24 was detected at the
highest amount of the Rev vector but could not be quan-
tified at the lowest (1 ng). Interestingly, in the presence of
Us11, p24 was detected whatever the amount of the
transfected Rev vector, the highest relative increase be-
ing observed with the subthreshold amount of Rev vector
(1 ng). Likewise, the immunoblot analysis of cell extracts
(Fig. 1B) revealed that HIV-1 envelope glycoproteins
could not be detected in cells transfected either with 1 ng
of Rev vector or with the Us11 expression plasmid,
whereas they were readily detected when both proteins
were provided in trans. In addition, cytoplasmic RNAs
were isolated from these transfected HeLa cells, and the
viral transcripts were analyzed by Northern blot (Fig. 1C).
Minute amounts of unspliced (9.2 kb) and singly spliced
(4.3 kb) RNAs could be observed in the cytoplasm of
cells transfected with a subthreshold amount of Rev
alone (lane 3). Conversely, the cotransfection of the Us11
plasmid together with a subthreshold amount of Rev led
to a significant cytoplasmic accumulation of unspliced
and singly spliced RNAs (lane 4). As expected, the dou-
bly spliced (2 kb) RNAs were found in the cytoplasm in
each transfection assay. This observation underlines a
Rev-Us11 cooperation to ensure the nuclear export of the
unspliced gag–pol and singly spliced env mRNAs.
After cotransfection of HeLa cells with the rev-deleted
provirus together with the wild-type Us11 and with a Rev
M10 mutant (which does not contain a functional NES),
p24 was not produced (Table 1). Likewise, p24 was not
produced when an Us11 protein deleted of the N-termi-
nal first 40 amino-acids was used in the HIV-1 rescue
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45HSV-1 US11-HIV-1 REV COOPERATION IN HIV-1 PRODUCTIONassay, in the presence of 1ng of the Rev vector (Table 1).
These observations therefore suggest that an efficient
Us11-Rev cooperation is dependent on functional do-
mains of both Us11 and Rev.
Finally, the ability of transfected cells to produce in-
1
FIG. 1. HSV-1 Us11 cooperates with HIV-1 Rev to rescue a rev-delete
of the Rev-defective HIV-1 provirus expression plasmid, pHIVDRev, toge
ars) or pCMV empty plasmid (white bars) and 100 ng of the indicator co
edia were harvested and levels of secreted p24 capsid protein
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46 DUC DODON ET AL.transfected with pHIVDRev and with both Us11 and Rev
expression plasmids, as shown by the high number of
X-Gal-stained blue cells (Fig. 1D). Collectively, these re-
sults indicate that Us11 is able to intervene in the HIV-1
life cycle, in the presence of Rev expressed at subopti-
mal levels, thus providing evidence for a Rev–Us11 co-
operation in rescuing a productive HIV-1 infection.
The Rev-Us11 cooperation is not mediated through
Us11-RNA binding
This cooperation was revealed by using vectors
placed under the control of the CMV promoter, raising
the possibility that any increase in HIV-1 replication was
due to the transcriptional activity of this promoter. Con-
sequently, the total molar amount of CMV promoter in
each transfection was held constant by the addition of
vector without gene sequences. Nevertheless we also
verified that Us11 had no transcriptional effect on Rev
expression. We first ascertained that HIV-1 production by
cells cotransfected with Us11 and suboptimal amounts
of Rev did not correlate with an increase in Rev expres-
sion. To this aim, HeLa cells were cotransfected with a
suboptimal amount (10 ng) of pcRev with either pCMV or
with pCMV-Us11 or pCMV-11sU (Fig. 2A, left). Cell ly-
sates prepared 48 h after transfection were then anal-
ysed for Rev content by Western blot analysis using an
anti-Rev antibody. At that concentration, Rev was unde-
tectable in HeLa cells even when transfected with
pCMV-Us11. When using a higher amount of pcRev (300
ng), Rev was readily detected, but no difference could be
detected in the Rev content of cells either transfected
with either pCMV or with pCMV-Us11 or pCMV-11sU (Fig.
2A, right). We next checked whether Us11 is increasing
the transcriptional activity of the CMV promoter. HeLa
TABLE 1
Effect of Rev and Us11 Mutants on HIV-1 Production
Cotransfected plasmids
HIV-1 p24 production
(pg/ml)
one 5.1 6 1.0
cRev (1 ng) 6.3 6 0.8
CMV-Us11 (1 mg) 5.3 6 0.2
pCMV-Us11 (1 mg) 1 pcRev (1 ng) 171.0 6 15.2
pCMV-Us11 (D1-40) (1 mg) 6.6 6 0.5
pCMV-Us11 (D1-40) (1 mg) 1 pcRev (1 ng) 7.7 6 1.4
pCMV-Us11 (1 mg) 1 pcRev M10 (1 ng) 6.4 6 1.2
Note. HeLa cells were transfected with 1 mg of the Rev-defective HIV-1
provirus expression plasmid together with the indicated expression plas-
mids and 100 ng of the internal control plasmid pRSV-SEAP. Forty-eight
hours after transfection, the culture media were harvested and levels of
secreted p24 gag protein and SEAP determined. Data shown are repre-
sentative of three independent transfections normalized for transfection
efficiency by SEAP values and performed in duplicate.cells were transfected with a plasmid encoding the CAT
gene driven by the CMV promoter (pCMV-CAT), togetherwith either pCMV or with pCMV-Us11 or pCMV-11sU. No
significant difference in the level of CAT activity could be
detected (Fig. 2B), indicating that Us11 does not exert
any transcriptional effect on the CMV promoter.
We have previously shown that Us11 binds specifically
to the RRE by gel shift analysis (Diaz et al., 1996). It has
been further demonstrated that the C-terminal half of
Us11 consisting of 20–24 XPR repeats is necessary and
sufficient to mediate RNA binding with high affinity and
specificity (Roller et al., 1996). However, the RNA-binding
specificity remains to be defined, and it is unclear
whether the SLIIB element, the Rev-binding site, may
also serve as an Us11-binding site, a possibility raised
by the Rev–Us11 cooperation in HIV-1 rescue. To ad-
dress this issue, we performed an in vivo RNA-binding
assay that relies on the transcriptional activation by the
HIV-1 Tat protein of the pSLIIB-CAT indicator construct
containing the cat sequences linked to an HIV-1 LTR in
which the TAR element RNA binding site for Tat has been
substituted by the RRE SLIIB (Fig. 3A). In this assay, the
FIG. 2. Us11 has no transcriptional effect on Rev expression. (A)
Immunoblot analysis of Rev expression in HeLa cells transfected with
either 10 ng (left) or 300 ng of pcRev (right), without or with pCMV-Us11
(200 ng). Forty-eight hours after transfection, cell lysates were analysed
by Western blotting using a mouse monoclonal antibody to Rev or a
rabbit anti-actin serum. (B) CAT activity expressed from the CMV pro-
moter in HeLa cells transfected with pCMV-CAT and with 250 ng of
either pCMV-Us11 or pCMV-11sU or pCMV. Forty eight hours after
transfection, cell lysates were quantified for CAT activity. Results are
expressed as picomoles of [3H]acetylchloramphenicol produced per
minute. The CAT activity represents the mean of three independent
experiments. The error bars represent the standard deviation of the
means.
t47HSV-1 US11-HIV-1 REV COOPERATION IN HIV-1 PRODUCTIONbinding ability of Us11 to the SLIIB RNA can be evaluated
by its capacity to recruit Tat to these heterologous target
sequences. We therefore constructed a vector in which
Us11 was fused to Tat by its N-terminal end, thus leaving
the C-terminal RNA-binding domain able to interact with
RNA. In HeLa cells cotransfected with the SLIIB-CAT and
Tat/US11 plasmids, it was observed that the Tat/Us11
fusion protein was unable to activate the HIV-1 LTR
bearing the SLIIB element in place of TAR (Fig. 3B).
Conversely and as expected, the Tat/Rev fusion protein
was found to be a potent activator of this construct. As
we verified that the Tat/Us11 protein was produced in
cotransfected cells (not shown), these data indicate that
Us11 is unable to specifically bind the SLIIB sequences
in vivo.
The Rev–Us11 cooperation is dependent
on protein–protein interactions
FIG. 3. Analysis of the RNA-binding properties of HSV-1 Us11 protein.
(A) Schematic representation of the SLIIB-CAT indicator construct. The
SLIIB-CAT indicator construct contains an HIV-1 LTR in which the TAR
RNA binding site for Tat has been substituted by the RRE SLIIB RNA
binding site for Rev. (B) Us11 does not bind directly the SLIIB RNA.
HeLa cells were transfected with 1 mg of the SLIIB indicator plasmid
ogether with 2 mg of Tat/rev or Tat/Us11 fusion protein expression
plasmids (*two preparations of the same plasmid were used). Trans-
fected cells were analyzed for CAT expression levels at 48 h posttrans-
fection. Results are expressed as fold induction of the HIV-1 LTR-linked
CAT indicator gene and represents the level of CAT obtained with the
indicated plasmid above that obtained with Rev alone. Average of three
independent transfections.We next asked whether this cooperation in rescuing
HIV from a rev-deleted provirus might be the conse-quence of a physical interaction of both viral proteins. To
evaluate these interactions, we performed a monohybrid
assay, using the SLIIB-CAT construct. As previously
shown (Bogerd et al., 1995), this indicator plasmid was
shown to be activated upon cotransfection of vectors of
the wild-type form of Rev and Tat fused with a protein
known to interact with Rev. Here, we have used a plas-
mid, pTat/Rab, expressing Tat fused to the nucleoporin-
like protein, Rab. The basal level of CAT expression
observed in HeLa cells transfected with pSLIIB-CAT did
not increase in the presence of either Rev or Tat/Rab
fusion protein. However, the cotransfection of the three
expression plasmids—pSLIIB-CAT, pcRev, and pTat/
Rab—induced a 20-fold induction in CAT protein expres-
sion (Fig. 4). Furthermore as expected from results
shown in Figure 3B, no increase in CAT expression could
be seen in HeLa cells cotransfected with pSLIIB-CAT and
pTat/Us11. However, when these two vectors were co-
transfected with pcRev, a seven- to eightfold increase in
the level of CAT expression was constantly observed.
These data clearly propose that Us11 is able to interact
with Rev bound to the SLIIB sequences.
To ascertain the in vivo interaction of Rev and Us11
proteins, extracts of HeLa cells transfected with both
Rev- and Us11-expression plasmids were subjected to
immunoprecipitation with an anti-Rev antibody followed
by immunoblotting using an anti-Us11 antiserum. Figure
5A shows that the anti-Rev antibody coprecipitated Us11.
Furthermore GST-pulldown experiments were performed
FIG. 4. Us11 binds to Rev bound to SLIIB RNA. When a Tat/Us11
fusion protein is coexpressed with Rev, the SLIIB-CAT indicator is
activated by recruitment of Tat to the SLIIB RNA target by the Us11-Rev
protein–protein interaction. This effect is not observed when either
protein is expressed alone or when Us11 is expressed unfused to Tat
protein. HeLa cells were transfected with 1 mg of pSLIIB-CAT and 2 mg
of pCMV-Tat/Us11 (*two preparations of the same plasmid were used)
or Tat/Rab with or without 500 ng of pcRev. Data shown are represen-
tative of four independent transfection experiments that were each
internally controlled by cotransfection with pRSV-SEAP.
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48 DUC DODON ET AL.by using GST fusion constructs. GST or GST-Rev was
incubated with a cell extract of Us11-transfected HeLa
cells and complexes were immobilized on glutathione
sepharose beads. Figure 5B shows that US11 specifi-
cally interacted with Rev. In addition, pulldown assays
were performed with GST-M10, containing a mutated
form of Rev bearing the M10 missense mutation known
to inactivate NES function. Interestingly, it was observed
that this mutation does not abolish the interaction be-
tween Rev and Us11. These observations underline the
association of US11 with Rev and indicate that the NES
of Rev is not involved in this interaction. They therefore
propose that the synergistic effect of Us11 in HIV rescue
in the presence of suboptimal amounts of Rev is linked to
the interaction of these viral proteins.
The Rev–Us11 cooperation remains hCRM1
dependent
The above results raised the question whether HIV-1
mRNAs are exported, in the presence of both Us11 and
of suboptimal amounts of Rev, through a pathway differ-
ent from that they used in the presence of an optimal
amount of Rev alone. It is now well established that the
Rev-mediated export depends on the leucine-rich nu-
clear export signal (NES) contained in the activation
domain of Rev (Fornerod et al., 1997; Fridell et al., 1996;
ollard and Malim, 1998). The fungal metabolite lepto-
ycin B (LMB) has been shown to specifically inhibit Rev
nd other NES-containing proteins by binding the NES-
inding receptor, hCRM1 (or exportin 1), thereby prevent-
ng the formation of NES-hCRM1 complex (Fornerod et
al., 1997; Wolff et al., 1997). Because Us11 does not
contain this class of NES, experiments were performed
to analyze the effect of LMB on the Rev–Us11-induced
cytoplasmic accumulation of intron-containing RNAs. To
that purpose, we have used the pCMV-RRE-CAT indica-
tor vector that encodes a single intron that contains both
the CAT coding and the RRE sequences. Efficient CAT
expression has been shown to be dependent on the
Rev/RRE function, allowing the nuclear export of un-
spliced cat mRNAs. Cotransfection of HeLa cells with
this plasmid and the Rev-, the Us11-, or the Rev- and
Us11-expression plasmids were performed. Results
shown in Fig. 6A indicate that Us11 was found to effi-
ciently cooperate with a suboptimal amount of Rev to
ensure the cytoplasmic expression of unspliced RRE-
containing cat mRNAs.
The effect of LMB was next assessed on the expres-
sion of CAT activity after cotransfection of HeLa cells
with pCMV-RRE-CAT together with pcRev and pCMV-
Us11. Control experiments were performed in which
HeLa cells were either transfected with pCMV-CAT
(which allows CAT expression, independently of Rev) or
cotransfected with pCMV-RRE-CAT and with an optimalamount of pcRev. LMB was found to inhibit Us11–Rev-
induced cytoplasmic accumulation of RRE-containing
RNAs, as shown by a 68% decrease of CAT activity,
compared to untreated cells, a percentage close to that
observed in the presence of Rev alone (75%), whereas
the antibiotic has no effect on CAT activity mediated by
pCMV-CAT (Fig. 6B). Collectively, these observations in-
dicate that the cytoplasmic expression of RRE-containing
RNAs in cells transfected with Us11 and a subthreshold
amount of Rev is exclusively dependent on the retroviral
protein, the export occurring through the CRM1-depen-
dent RNA pathway. Furthermore they show that the Us11
protein is not directly involved in the nuclear export of
FIG. 5. In vitro and in vivo analysis of Rev–Us11 cooperation. (A) In
ivo coimmunoprecipitation of Us11 and Rev. HeLa cells were left
ntransfected or transfected with pCMV-Us11 (7 mg) or with pcRev (7
mg) or with both. Forty-eight hours after transfection, cells were lysed in
Nonidet-P40 lysis buffer as described under Material and Methods. Rev
was immunoprecipitated from the different cell lysates with an anti-Rev
monoclonal antibody, and immune complexes were resolved by SDS–
PAGE. After blotting, the membrane was probed with the rabbit anti-
Us11 antiserum. A total of 10 mg of lysate from Rev–Us11-transfected
cells was also subjected to WB with the anti-Us11 antiserum and is
shown as input. (B) GST-pulldown assays demonstrating in vitro inter-
action between Us11 and Rev or the M10 Rev mutant for NES. Lysates
from untransfected (2) or Us11-transfected (1) HeLa cells were incu-
bated in solution with GST or GST-Rev or GST-M10 fusion proteins and
gluthatione–Sepharose beads. Bound proteins were eluted from beads
and revealed by chimioluminescence following SDS–PAGE. An amount
of lysates from untransfected and Us11-transfected HeLa cells corre-
sponding to 1/20 of that added to reactions is shown as input.RRE-containing RNAs and suggest that Us11 functions
as an auxiliary protein.
i
R
r
r
i
t
o
a
U
H
p
U
a
p
l
t
r
a
i
m
t
s
q
f
e
t
s
i
c
n
t
o
L
i
n
C
U
t
t
o
r
a
i
e
a
3
S
w
c
T
R
e
l
v
t
d
p
p
e
e
u
U
49HSV-1 US11-HIV-1 REV COOPERATION IN HIV-1 PRODUCTIONDISCUSSION
The Us11 protein, expressed at late times in cells
nfected with HSV-1, (Roizman and Sears, 1996) is an
NA-binding protein that specifically associates with 60S
ibosomal protein subunits and nucleoli and is incorpo-
ated into virions. Its RNA-binding ability is mediated by
ts carboxyl-terminal half, consisting of a regular tripep-
ide repeat of the sequences RXP, thus constituting an
riginal RNA-binding domain (Roller et al., 1996; Roller
nd Roizman, 1991, 1992). We have previously shown that
s11 is able to functionally substitute for HTLV-1 Rex and
IV-1 Rev, in inducing the expression of envelope glyco-
roteins of these retroviruses. This effect is mediated by
s11 binding to XRE or RRE, as shown by gel shift
nalysis. However, most of these experiments have been
erformed with unspliceable expression vectors, under-
ining that this biological activity of Us11 is restricted to
hese particular constructs. Thus Us11 was unable to
escue in trans HIV-1 expression in cells transfected with
rev-deleted HIV-1 provirus (Diaz et al., 1996).
In the present study, we confirmed that Us11 was
nefficient in upregulating HIV-1 production and docu-
ented that this HSV-1 protein was unable to promote
he cytoplasmic CAT expression from an indicator con-
truct in which this bacterial gene and the RRE se-
uences were inserted between two splice sites. We
urther showed that Us11, when expressed in the pres-
nce of suboptimal amounts of Rev, displays the ability
o upregulate HIV-1 replication. Likewise, under the
ame conditions, Us11 was found to operate in promot-
ng the cytoplasmic CAT expression from the indicator
onstruct. After having verified that Us11 expression did
ot lead to an increase in Rev expression, we showed
hat the export of RRE-containing RNAs, in the presence
f Us11 and suboptimal amounts of Rev, is blocked by
MB, a specific inhibitor of hCRM1 function. These data
ndicate that these transcripts are exported out of the
uclei via a hCRM1-mediated nuclear export pathway.
ollectively, these results clearly provide evidence that
s11 is able to compensate for Rev provided in subop-
imal amounts, allowing the retroviral regulatory pro-
ein to fulfill its functional activity. Consequently, these
bservations underline a Rev-US11 cooperation in HIV-1
eplication.
We next attempted to approach the molecular mech-
nisms of this cooperation by using an RNA:protein bind-
ng assay permitting us to explore whether Us11 is able
ither to bind the SLIIB Rev-target sequences of the RRE
nd/or to associate with Rev. The data presented in Figs.
and 4 demonstrate that Us11 is unable to bind the
LIIB sequences but is able to interact with Rev. They
ere further confirmed by the results of coimmunopre-
ipitation and GST-pulldown assays (Figs. 5A and 5B).
aken together, these observations suggest that the
ev–Us11 association is underlying the Rev–Us11 coop-
a
wration in HIV-1 replication. Interestingly, Us11 is also
FIG. 6. Effect of Rev–Us11 cooperation in the RNA export activity. The
pCMV-RRE-CAT construct contains the CAT gene and the HIV-1 RRE
located in an intron defined by HIV-1 splice sites. Efficient CAT expres-
sion is therefore dependent on the Rev-induced nuclear export of an
unspliced form of this RNA. (A) HeLa cells were transfected with 0.4 mg
of pCMV-RRE-CAT, 0.1 mg of pRSV-SEAP, and expression pc Rev or/and
pCMV-Us11. Cells were harvested 48 h after transfection and CAT
activity determined. Results are expressed as picomoles of [3H]acety-
ated chloramphenicol produced per minute and represent the mean of
alues from three independent experiments. The error bars represent
he standard deviation of the means. (B) Rev–Us11 function is hCRM1
ependent. pCMV-RRE-CAT was cotransfected into HeLa cells with
CMV-Us11 (h), 10 ng of pcRev (), 200 ng of pcRev (), or 10 ng of
cRev and pCMV-Us11 (f). pCMV-CAT (E), a Rev-independent CAT
xpression plasmid, was transfecte d into HeLa cells under the same
xperimental conditions. Twenty hours after transfection, cells were left
ntreated or treated with 1 or 2 nM of LMB. LMB inhibits only Rev–
s11-mediated CAT activity by 25% at 1 nM and 68% at 2 nM.ble to interact with the M10 mutant form of the Rev NES,
hich is unable to interact with hCRM1, indicating that
l
l
o
a
U
e
m
f
t
e
H
p
a
r
p
t
H
i
c
a
h
s
A
S
i
a
r
A
s
b
s
50 DUC DODON ET AL.this cellular protein is not involved in the association of
Us11 with Rev and that this association does not require
a functional NES. However, this observation does not
exclude the possibility that Us11 is independently able to
associate with the cellular factor.
We have previously shown that Us11 deleted of the
first 40 amino-acids of the N-terminal region was unable
to mediate the posttranscriptional expression of HIV-1
envelope glycoproteins (Diaz et al., 1996). As shown in
the present study, this deleted Us11 protein was found to
be unable to cooperate with Rev in upregulating HIV-1
production. These data underline the critical role of this
domain, which has recently been suggested to be an
effector domain, probably interacting with cellular pro-
teins. This deletion has also been shown to lead to the
formation of oligomers having a size greater than that of
those observed with the wild-type protein (Schaerer-
Uthurralt et al., 1998). Given the observation that upregu-
ation of HIV-1 replication is not observed with this de-
eted form of Us11 in the presence of subthreshold levels
f Rev, it might be that this US11 mutant is unable to
ssociate with Rev.
Studies that have investigated the properties of
s11 have underlined that, during viral evolution, more
fficient mechanisms than those controlled by Us11
ight have recently been acquired by HSV-1 to per-
orm the same task as that previously carried out by
his viral protein. Thus the g134.5 protein may have
volved following the acquisition by a progenitor of
SV-1 of a portion of cellular gene to supplant Us11 in
recluding the shutoff of protein synthesis (Cassady et
l., 1998). The fact that Us11 has nevertheless been
etained by the HSV-1 genome indicates that this viral
rotein has acquired additional functions. In that con-
ext, it is not unexpected that in cells coinfected by
IV-1 and HSV-1, this RNA-binding viral protein is
nvolved in the cytoplasmic expression of mRNAs en-
oded by this complex retrovirus.
As stated in the Introduction, herpesviruses, and
mong them HSV-1, which have been shown to have a
igh prevalence in certain high-risk populations, are con-
idered as important cofactors in the pathogenesis of
IDS (Cavert, 1997; Mole et al., 1997; Quinn et al., 1987).
everal experimental studies have analyzed HIV-1/HSV-1
nteractions in HIV-1 target cells (CD41 T lymphocytes
nd monocytes-macrophages) to determine the clinical
elevance of these interactions. Thus in patients with
IDS, a reciprocal enhancement of viral replication was
hown to be associated with coinfection of macrophages
y HIV-1 and HSV-1 (Heng et al., 1994). Likewise, HIV-1
uperinfection of CD41 T lymphocytes persistently in-
fected with HSV-1 resulted in significant potentiation of
HIV-1 replication in cells chronically infected by both
viruses with production of HIV-1 pseudotyped by HSV-1
envelope (Calistri et al., 1999). By using HSV-1 mutants
with deletions in the genes encoding immediate-earlyproteins ICP0, ICP4, and ICP27, it was found that ICP0
and ICP27, but not ICP4, were essential for upregulation
of HIV-1 replication (Golden et al., 1992). Transient-ex-
pression transfection assays using LTR HIV-1 CAT plas-
mids have shown that ICP0 stimulates HIV-1 LTR tran-
scription in the frame of a cooperation with the cellular
NF-kB factor activated by HSV-1 (Vlach and Pitha, 1993).
Furthermore it has been demonstrated that ICP27 medi-
ates the nuclear export of HSV transcripts through a
leucine-rich nuclear export signal and binding viral RNAs
through an RGG motif (Phelan et al., 1996; Sandri-Goldin,
1998).
The present report provides evidence that another
HSV-1 gene product is affecting viral expression at a
posttranscriptional level as shown by the ability of Us11
to cooperate with Rev in favoring the release from HIV-1
latency. The data presented here suggest that Us11 may
be acting on Rev-dependent export of intron containing
viral RNAs through a new and important mechanism. The
fact that Us11 stimulates the export of unspliced HIV-1
RNAs by suboptimal amounts of Rev could be due to
Us11-induced Rev oligomerization and binding to the
RRE. Our results suggest that this is not due to binding of
Us11 to the SLIIB minimal RNA target sequence but more
likely to a direct interaction between Rev and Us11.
Indeed, in this report, we present in vitro and in vivo
evidences for such an interaction, which might stabilize
the binding of Rev to the RRE. The gross effect would be
an increased accessibility of the Rev NES to CRM1,
and/or a more efficient competition of Rev/Us11 with
spliceosome assembly, facilitating the export of HIV-1
unspliced RNAs. Finally, the demonstration that the
Us11–Rev cooperation remains hCRM1-dependent fur-
ther indicates that Us11 may be defined as an auxiliary
protein able to complement Rev activity.
MATERIALS AND METHODS
Plasmids
The expression plasmids used have been previously
described. Unless otherwise indicated, they contain the
indicated sequences under the transcriptional control of
the cytomegalovirus (CMV) promoter. pCMV-CAT en-
codes the bacterial cat (chloramphenicol acetyl trans-
ferase) gene. pCMV-RRE-CAT, derived from pDM128 in
which the simian virus 40 promoter was replaced by the
CMV promoter, encodes the cat gene and the HIV-1 RRE
located between two HIV-1-derived splice sites (Hope et
al., 1991). pcRev and pcRevM10 encode the wild-type Rev
and the Rev M10 activation domain mutant, respectively
(Malim et al., 1991); pCMV-Us11 and pCMV-Us11 (D1–40)
encode the wild-type Us11 and a mutant deleted of the
first N-terminal 40 amino-acids, respectively (Diaz et al.,
1996). pCMV-11sU contains Us11 cDNA inserted in the
reversed orientation (Diaz et al., 1996). pSLIIB-CAT con-
tains the cat gene linked to the HIV-1 LTR in which the
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51HSV-1 US11-HIV-1 REV COOPERATION IN HIV-1 PRODUCTIONTAR element was replaced by the stem–loop IIB (SLIIB)
sequence of the RRE (Bogerd et al., 1995). pSLIIB-CAT,
pHIVDRev, a Rev-defective HIV-1 provirus expression
plasmid (Rimsky et al., 1988), pTat/Rab and pTat/Rev
ncoding Tat fused to either Rev or Rab proteins (Bogerd
t al., 1995), and pRSV-SEAP encoding phosphatase al-
aline (SEAP) (Malim et al., 1991) were provided by B.
ullen. The pTat/Us11 encoding a Tat/Us11 fusion pro-
ein was generated by insertion of a Us11-PCR amplifi-
ation fragment using a 59 primer that introduced a
nique NcoI site and a 39 primer with an AvaI site into a
CMV plasmid. The primers used were as follows: sense
rimer (59-TGGCTCTCGCCAATGGCCAGA-39), antisense
rimer (59-ATACTTGCCCGGGTATACAGACC-39). Then the
ull-length HIV-1 tat gene was isolated from pTat/Rab by
coI digestion and inserted at the NcoI site of pCMV-
s11. The obtained plasmid encodes HIV-1 Tat fused to
ull-length HSV-1 Us11. Expression of both proteins was
erified by Western immunoblotting.
ell culture, transfection, CAT, and SEAP assays
H12 indicator cells are HeLa CD41 cells carrying the
acterial LacZ gene under the control of HIV-1LTR (Char-
eau et al., 1992). Both H12 and HeLa parental cells were
ultured in MEM supplemented with 10% fetal calf serum
FCS), penicillin, streptomycin, and fungizone (Life Tech-
ologies). These cells, seeded at 1 3 105 cells/35-mm
ish, were transfected with 2 mg of plasmid DNA per
ish, using the calcium phosphate precipitation method
Chen and Okayama, 1987). The respective concentra-
ions of plasmid DNA used in each transfection assay
re given in the relevant figure legend, pRSV-SEAP (100
g) being always included as an internal control. When
ecessary, pCMV carrying the CMV promoter without the
ene sequences was included such that the total molar
mount of CMV promoter was used in each transfection
ssay. For the monohybrid assay, HeLa cells were trans-
ected with 3.6 mg of plasmid DNA: pSLIIB-CAT (1 mg),
pcRev (0.5 mg), pRSV-SEAP (0.1 mg), and pTat/Us11 pro-
ein (2 mg). Two days after transfection, cells were har-
ested, lysed by five repeated freeze–thaw cycles and
nalysed for CAT activity (Neumann et al., 1987). The
btained values were then normalized for transfection
fficiency related to values of SEAP activity as deter-
ined by using a chemiluminescent reporter kit (Aurora-
EN). When the effect of leptomycin B (LMB) was tested,
alcium phosphate transfections were performed as de-
cribed above. However, to achieve similar transfection
fficiencies, the precipitates were divided in half and
dded to cells that either will be treated with LMB or not.
ighteen hours later, the culture medium was replaced
ith fresh medium containing 1 or 2 nM LMB or withresh medium alone. Cells were harvested 40 h after
ransfection and prepared for CAT analysis.IV-1 rescue, p24 assays, and titration of infectious
iral particles
HeLa cells were transfected by using the calcium
hosphate method with 1 mg of pHIVDRev (a Rev-defec-
tive HIV-1 provirus expression plasmid) together with
pcRev at the appropriate concentration and 1 mg of
CMV-Us11 or 1 mg pCMV empty plasmid and 100 ng of
internal control plasmid pRSV-SEAP. Forty-eight hours
after transfection, the culture media were collected and
filtered. They were titrated to determine the number of
infectious units of HIV. Briefly, H12 cells (HeLa-CD41-
LTR-b-galactosidase-cells) were infected with serial di-
lutions of the transfection supernatants. Two days later,
the cells were fixed and stained with X-Gal, and the
blue-stained infectious centers were counted. Likewise,
these transfection supernatants were also assayed for
the HIV capsid antigen, p24, using a commercial en-
zyme-linked immunosorbent assay (ELISA) kit (Coulter,
Hialeah, FL), as instructed by the manufacturer. The
amount of SEAP activity present in the supernatant was
assayed as outlined above.
RNA preparation and northern blot analysis
Cytoplasmic RNAs were extracted from HeLa cells, 48 h
after transfection, as previously described (Chomczynski
and Sacchi, 1987). Equivalent amounts of RNA were sepa-
rated on a 1% formaldehyde-agarose gel and transferred
to a Hybond-N membrane (Appligene). The RNA on the
membrane was then hybridized using a random-primed
[a-32P]dCTP-labeled probe prepared from a nef LTR frag-
ment containing sequences common to the 39 ends of all
HIV-1 transcripts. Hybridization was carried out at 42°C in
buffer containing 50% (vol/vol) formamide and 43 SSC (13
SSC is 0.15 M NaCl plus 0.015 M sodium citrate). The
membrane was washed in 0.13 SSC for 20 min at 68°C and
exposed for autoradiography.
Antibodies and immunoblot analysis
The following unconjugated antibodies were used.
Anti-Us11 is a polyclonal rabbit antiserum raised against
a fused GST-Us11 protein (Diaz et al., 1993). Rabbit anti-
HIV-1 gp120 serum was kindly provided by K. Sanhadji.
Anti-Rev (a gift from B. Wolff) is a monoclonal mouse
antibody. Anti-actin, a polyclonal rabbit antiserum, was
purchased from Sigma. Horseradish peroxidase-conju-
gated F(ab9)2 goat anti-rabbit or anti-mouse immunoglob-
ulin G IgG (H1L) was purchased from Immunotech.
After transfection of HeLa cells with the indicated
plasmids, cells were washed with ice-cold PBS, har-
vested in Laemmli sample buffer, and then boiled. Equal
amounts of lysates were resolved on sodium dodecyl
sulfate SDS-10% polyacrylamide gel electrophoresis, and
blotted onto nitrocellulose membranes BA85; Schleicher
& Schu¨ll). Membranes were blocked with a 10% nonfat
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52 DUC DODON ET AL.milk-0.1% Tween 20-PBS solution for 1 h at room temper-
ature and incubated overnight at 4°C with the appropri-
ate concentration of the first specific antibody. After
washings, blots were incubated with horseradish perox-
idase-conjugated (HRP) second antibody and developed
using an enhanced chemiluminescence detection sys-
tem (Renaissance-NEN). The membranes were sub-
jected to autoradiography with Hyperfim MP (Amersham).
Coimmunoprecipitation assays
HeLa cells seeded at 1 3 106 cells per 100-mm petri
ish, were transfected with either pCMV-Us11 or pcRev
xpression plasmids (7 mg of each plasmid) or cotrans-
fected with both plasmids according to the standard
calcium phosphate precipitation procedure as described
above. Forty-eight hours after transfection, cells were
washed once in cold PBS and lysed at 4°C for 1 h in a
500 ml lysis buffer (20 mM Tris–HCl, pH 7.8, 140 mM
aCl, 1 mM EDTA, 50 mM sodium fluoride, 1 mM PMSF)
ontaining 0.5% (v/v) Nonidet-P40 detergent. Cellular de-
ris and nuclei were removed by centrifugation at 10,000
for 30 min, and the amount of proteins in each super-
atant was determined. The cellular lysates (300 mg)
ere then diluted with 300 ml of immunoprecipitation
buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 0.1% Nonidet-
P40, 1 mM EDTA, 0.25% gelatin) and treated with anti-Rev
antibody for 2 h at 4°C. The immune complexes were
then collected on Dynabeads M-450 goat anti-mouse
IgG (Dynal, Norway) and subjected to immunoblotting
analysis (as described in the previous section), using a
rabbit anti-Us11 antiserum.
GST-Rev and GST-M10 pulldown of Us11
from Us11-expressing HeLa cells
Expression and purification of GST, GST-Rev, and GST-
M10 were performed by standard procedures except that
2% N-laurylsarkosyl, 4% Triton X-100, and 5 mM DTT
were added to the extraction buffer. Purified GST, used
as control (5 mg) or GST-Rev or GST-M10 fusion proteins
(0.5 mg) together with purified GST (4.5 mg) were incu-
ated with 5 ml of a 50% slurry solution of glutathione–
Sepharose beads (Amersham Life Science) in a final 100
ml of binding buffer (10% glycerol, 20 mM HEPES, pH 7.5,
50 mM KCl; 50 nM ZnCl2, 2.5 mM MgCl2, 0.5% Nonidet-
P40, 1 mM DTT, 1 mM PMSF) containing 100 mg of
ellular extract of transfected HeLa cells prepared as
escribed in the previous section. The pulldowns were
ncubated for 2 h at 4°C with rotation and the beads were
hen washed five times with 500 ml of binding buffer
ontaining 300 mM KCl. Bound proteins released by
oiling in loading buffer were resolved on SDS-10% poly-
crylamide gels and transferred to nitrocellulose mem-
ranes as described above. The membranes were then
lotted with the rabbit Us11 antibody and proteins were
isualized as indicated above.ACKNOWLEDGMENTS
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